NCT02312830View on ClinicalTrials.gov

Belgian Cross-sectional Allogeneic Transplant Survivor Study

Enrolling by invitationOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Hematopoietic Stem Cell TransplantationHematopoietic Stem Cell Transplantation, Allogeneic

All Listed Sponsors

lead

Universitaire Ziekenhuizen KU Leuven

OTHER